EGFR Polymorphism as a Predictor of Clinical Outcome in Advanced Lung Cancer Patients Treated with EGFR-TKI

PURPOSE: Mutations in the epidermal growth factor receptor (EGFR) have been confirmed as predictors of the efficacy of treatment with EGFR-tyrosine kinase inhibitors (TKIs). We investigated whether polymorphisms of the EGFR gene were associated with clinical outcomes in non-small cell lung cancer (N...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Jung, Minkyu, Cho, Byoung Chul, Lee, Chul Ho, Park, Hyung Soon, Kang, Young Ae, Kim, Se Kyu, Chang, Joon, Kim, Dae Jun, Rha, Sun Young, Kim, Joo Hang, Lee, Ji Hyun
Format: Artigo
Idioma:Inglês
Publicat: Yonsei University College of Medicine 2012
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3481391/
https://ncbi.nlm.nih.gov/pubmed/23074112
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3349/ymj.2012.53.6.1128
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars